EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Allosterism in the adenosine A 2A and cannabinoid CB 2 heteromer

Claudia Llinas Del Torrent iD, Iu Raïch, Angel Gonzalez, Jaume Lillo, Nil Casajuana-Martin, Rafael Franco iD, Leonardo Pardo, Gemma Navarro iD

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.16502 ↗

At a glance

Journal article in British Journal of Pharmacology, 2025. Written by Claudia Llinas Del Torrent and 7 co-authors. Institution: Laboratory of Computational Medicine, Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra (Barcelona), Spain. Major MEDLINE topics: Receptor, Adenosine A2A, Receptor, Cannabinoid, CB2. Cited 16 times so far (Crossref); 64 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Spanish Ministry of Economy and Innovation, Generalitat de Catalunya, FPI fellowship.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Allosterism is a regulatory mechanism for GPCRs that can be attained by ligand‐binding or protein–protein interactions with another GPCR. We have studied the influence of the dimer interface on the allosteric properties of the A 2A receptor and CB 2 receptor heteromer. Experimental Approach We have evaluated cAMP production, phosphorylation of signal‐regulated kinases (pERK1/2), label‐free dynamic mass redistribution, β‐arrestin 2 recruitment and bimolecular fluorescence complementation assays in the absence and presence of synthetic peptides that disrupt the formation of the heteromer. Molecular dynamic simulations provided converging evidence that the heteromeric interface influences the allosteric properties of the A 2A R–CB 2 R heteromer. Key Results Apo A 2A R blocks agonist‐induced signalling of CB 2 R. The disruptive peptides, with the amino acid sequence of transmembrane (TM) 6 of A 2A R or CB 2 R, facilitate CB 2 R activation, suggesting that A 2A R allosterically prevents the outward movement of TM 6 of CB 2 R for G protein binding. Significantly, binding of the selective antagonist SCH 58261 to A 2A R also facilitated agonist‐induced activation of CB 2 R. Conclusions and Implications It is proposed that the A 2A R–CB 2 R heteromer contains distinct dimerization interfaces that govern its functional properties. The molecular interface between protomers of the A 2A R–CB 2 R heteromer interconverted from TM 6 for apo or agonist‐bound A 2A R, blocking CB 2 R activation, to mainly the TM 1/7 interface for antagonist‐bound A 2A R, facilitating the independent opening of intracellular cavities for G protein binding. These novel results shed light on a different type of allosteric mechanism and extend the repertoire of GPCR heteromer signalling. LINKED ARTICLES This article is part of a themed issue Complexity of GPCR Modulation and Signaling (ERNST). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.14/issuetoc

Subjects

MeSH terms (MEDLINE)

Receptor, Adenosine A2AReceptor, Cannabinoid, CB2HumansAllosteric RegulationMolecular Dynamics SimulationHEK293 CellsCyclic AMPProtein MultimerizationAnimals

Author keywords

A2AR–CB2R heteromerallosterismmodulationmolecular interface

Substances

Receptor, Adenosine A2AReceptor, Cannabinoid, CB2Cyclic AMP

Authors and institutions

  • Laboratory of Computational Medicine, Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra (Barcelona), Spain.
  • Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain.
  • Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Institute of Neuroscience, University of Barcelona (NeuroUB), Barcelona, Spain.
  • Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.

ORCID profiles: Claudia Llinas Del Torrent, Rafael Franco, Gemma Navarro

Funding

  • Spanish Ministry of Economy and Innovation
  • Generalitat de Catalunya
  • FPI fellowship

Cite

APA

Llinas Del Torrent, C., Raïch, I., Gonzalez, A., Lillo, J., Casajuana-Martin, N., Franco, R., Pardo, L., & Navarro, G. (2025). Allosterism in the adenosine A 2A and cannabinoid CB 2 heteromer. British Journal of Pharmacology. https://doi.org/10.1111/bph.16502

Vancouver

Llinas Del Torrent C, Raïch I, Gonzalez A, Lillo J, Casajuana-Martin N, Franco R, et al. Allosterism in the adenosine A 2A and cannabinoid CB 2 heteromer. British Journal of Pharmacology. 2025. doi:10.1111/bph.16502

BibTeX
@article{LlinasDelTorrent2025,
  author = {Llinas Del Torrent, Claudia and Raïch, Iu and Gonzalez, Angel and Lillo, Jaume and Casajuana-Martin, Nil and Franco, Rafael and Pardo, Leonardo and Navarro, Gemma},
  title = {Allosterism in the adenosine A 2A and cannabinoid CB 2 heteromer},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.16502}
}
Start for free →